BEAM Collar Strategy
BEAM (Beam Therapeutics Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Beam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily within the United States. The company's developmental portfolio features several key candidates: BEAM-101 is being advanced to treat both sickle cell disease and beta thalassemia. BEAM-102 is specifically designed for addressing sickle cell disease. BEAM-201, an allogeneic chimeric antigen receptor T-cell therapy, is under investigation for individuals suffering from relapsed or refractory T-cell acute lymphoblastic leukemia. BEAM-301 is a liver-targeted candidate aimed at patients afflicted with Glycogen Storage Disease Type Ia.
BEAM (Beam Therapeutics Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.58B, a beta of 2.20 versus the broader market, a 52-week range of 15.6-36.88, average daily share volume of 2.1M, a public-listing history dating back to 2020, approximately 393 full-time employees. These structural characteristics shape how BEAM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.20 indicates BEAM has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a collar on BEAM?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current BEAM snapshot
As of June 30, 2026, spot at $34.75, ATM IV 80.00%, IV rank 39.90%, expected move 22.94%. The collar on BEAM below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this collar structure on BEAM specifically: IV regime affects collar pricing on both sides; mid-range BEAM IV at 80.00% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 22.94% (roughly $7.97 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BEAM expiries trade a higher absolute premium for lower per-day decay. Position sizing on BEAM should anchor to the underlying notional of $34.75 per share and to the trader's directional view on BEAM stock.
BEAM collar setup
The BEAM collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BEAM near $34.75, the first option leg uses a $36.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BEAM chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BEAM shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $34.75 | long |
| Sell 1 | Call | $36.00 | $1.98 |
| Buy 1 | Put | $33.00 | $2.18 |
BEAM collar risk and reward
- Net Premium / Debit
- -$3,495.00
- Max Profit (per contract)
- $105.00
- Max Loss (per contract)
- -$195.00
- Breakeven(s)
- $34.95
- Risk / Reward Ratio
- 0.538
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
BEAM collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on BEAM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$195.00 |
| $7.69 | -77.9% | -$195.00 |
| $15.37 | -55.8% | -$195.00 |
| $23.06 | -33.6% | -$195.00 |
| $30.74 | -11.5% | -$195.00 |
| $38.42 | +10.6% | +$105.00 |
| $46.10 | +32.7% | +$105.00 |
| $53.79 | +54.8% | +$105.00 |
| $61.47 | +76.9% | +$105.00 |
| $69.15 | +99.0% | +$105.00 |
When traders use collar on BEAM
Collars on BEAM hedge an existing long BEAM stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
BEAM thesis for this collar
The market-implied 1-standard-deviation range for BEAM extends from approximately $26.78 on the downside to $42.72 on the upside. A BEAM collar hedges an existing long BEAM position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current BEAM IV rank near 39.90% is mid-range against its 1-year distribution, so the IV signal is neutral; the collar thesis on BEAM should anchor more to the directional view and the expected-move geometry. As a Healthcare name, BEAM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BEAM-specific events.
BEAM collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BEAM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BEAM alongside the broader basket even when BEAM-specific fundamentals are unchanged. Always rebuild the position from current BEAM chain quotes before placing a trade.
Frequently asked questions
- What is a collar on BEAM?
- A collar on BEAM is the collar strategy applied to BEAM (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With BEAM stock trading near $34.75, the strikes shown on this page are snapped to the nearest listed BEAM chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are BEAM collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the BEAM collar priced from the end-of-day chain at a 30-day expiry (ATM IV 80.00%), the computed maximum profit is $105.00 per contract and the computed maximum loss is -$195.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BEAM collar?
- The breakeven for the BEAM collar priced on this page is roughly $34.95 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BEAM market-implied 1-standard-deviation expected move is approximately 22.94%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on BEAM?
- Collars on BEAM hedge an existing long BEAM stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current BEAM implied volatility affect this collar?
- BEAM ATM IV is at 80.00% with IV rank near 39.90%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.